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To maintain genome stability, cells need to replicate
their DNA before dividing. Upon completion of bulk
DNA synthesis, the mitotic kinases CDK1 and PLK1
become active and drive entry into mitosis. Here,
we have tested the hypothesis that DNA replication
determines the timing of mitotic kinase activation.
Using an optimized double-degron system, together
with kinase inhibitors to enforce tight inhibition of key
proteins, we find that human cells unable to initiate
DNA replication prematurely enter mitosis. Prevent-
ing DNA replication licensing and/or firing causes
prompt activation of CDK1 and PLK1 in S phase. In
the presence of DNA replication, inhibition of CHK1
and p38 leads to premature activation of mitotic ki-
nases, which induces severe replication stress. Our
results demonstrate that, rather than merely a cell
cycle output, DNA replication is an integral signaling
component that restricts activation of mitotic ki-
nases. DNA replication thus functions as a brake
that determines cell cycle duration.
INTRODUCTION
Cell proliferation is critical to the propagation of life and in eu-
karyotes is based on mitotic cell division. Mitotic cell division
requires two basic steps: first, cells need to replicate their
DNA, and second, cells need to divide the replicated genome
to daughter cells. Strict separation of these steps in time is crit-
ical as division of partially duplicated chromosomes causes
genome instability and cell death (Boddy et al., 1998; Piatti
et al., 1995; Tercero et al., 2000). Furthermore, activation of
mitotic factors during DNA replication causes replication fork
instability and DNA damage (Beck et al., 2010; Neelsen et al.,
2013). How cells coordinate genome duplication and mitosis
thus constitutes a fundamental question in cell cycle control,Molecular Cell 71, 117–12
This is an open access article undwhich has major consequences for both proliferation and
genome stability.
Almost 30 years ago, Hartwell and Weinert introduced the
concept of a checkpoint and described it as a safety mechanism
that prevents cell division if DNA replication is not complete
(Hartwell and Weinert, 1989). However, empirical data support-
ing an intrinsic DNA replication checkpoint proved hard to
obtain, as treatments to block DNA replication fork progression
are prone to cause DNA damage, evoking secondary responses
that halt mitotic progression (Kurose et al., 2006; Natsume et al.,
2017). The concept of a checkpoint soon expanded and
became increasingly used to depict a cell cycle block in
response to DNA damage and other cellular stresses. Stress-
induced checkpoints have been widely studied, which has led
to the identification of well-conserved signaling kinases, such
as CHK1 and p38 (Bulavin et al., 2002; Reinhardt and Yaffe,
2009). Meanwhile, the discovery of autonomous biochemical
oscillators in yeast cells and de-nucleated Xenopus egg extracts
provided alternative models that could explain orderly cell cycle
progression without the need of a DNA replication checkpoint
(Haase and Reed, 1999; Newport and Kirschner, 1984; Stern
and Nurse, 1996). That is, self-regulating oscillators could in
principle ensure sufficient time to finish DNA replication before
mitosis is triggered.
The key to understand how DNA replication and cell division
are separated is to understand how cell division is initiated.
Mitotic entry is driven by the kinases CDK1 and PLK1, which
through multiple feedback loops enhance each other’s activity
(Lindqvist et al., 2009). Activation of CDK1 depends on CDK2-
mediated accumulation ofmitotic inducers, such as PLK1, which
at a threshold level can induce a switch-like activation and
mitotic entry. The threshold is defined by factors opposing
CDK1 activation, including PP1 and PP2A phosphatases and
Wee1/Myt1 kinases (He´garat et al., 2016). In addition, check-
point kinases as CHK1 and p38-MK2 can raise the activation
threshold through phosphorylation of multiple CDK regulators
(Reinhardt and Yaffe, 2009), effectively suppressing CDK
activity in the presence as well as absence of exogenous DNA
damage (Beck et al., 2010; Rodrı´guez-Bravo et al., 2007; Søren-
sen et al., 2004; Warmerdam et al., 2013). However, if and how8, July 5, 2018 ª 2018 The Authors. Published by Elsevier Inc. 117
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. Plk1 Activation Correlates to Completion of DNA Replication
(A) Schematic of hypothesis.
(B) Example of RPE cell expressing PLK1-FRET and PCNA-cb in S phase, G2 phase, and mitosis. Time between images is 20 min. Please note negative cor-
relation between nuclear PLK1 activity and presence of PCNA-cb foci.
(C) S phase cells expressing PCNA-cb foci were imaged every 20 min and either mock treated or exposed to 2.5 mM thymidine. (Top) Single-cell examples of
PLK1 activity and PCNA foci quantifications are shown. (Bottom) Color-coded heatmap of PLK1 activity and PCNA-cb quantifications of multiple single cells are
shown. Dotted line highlights temporal correlation between DNA replication completion and PLK1 activation. Further characterization of thymidine-induced
S phase arrest is described in Figure S1.
(D) U2OS, RPE, or BJ cells were fixed after a 1-hr EdU pulse andmonitored by high-content microscopy. Cells were sorted based on cyclin A2 levels and nuclear
size and plotted versus estimated time (Akopyan et al., 2016). Graphs showmovingmedian and SD of EdU signal and pTCTP signal from >1,600 single cells. EdU
incorporation is used to measure DNA replication in single cells. pTCTP signal is corrected by treating a control population with the Plk1 inhibitor BI2536.
A stepwise scheme of simultaneous cell cycle and TCTP phosphorylation analysis is described in Figure S2.unperturbed DNA replication is integrated into this regulatory cir-
cuit remains unknown. We previously showed that both CDK1
and PLK1 are activated when the bulk of DNA replication is
completed at the S/G2 transition (Akopyan et al., 2014). These
observations resurged the prospect of the original checkpoint
model and prompted us to test whether DNA replication restricts
mitotic kinase activation (Figure 1A).
Here, we generated a double-degron system to rapidly
deplete the essential DNA replication-initiation factor CDC6
and show that untransformed human cells shorten the cell cycle
and prematurely enter mitosis in the absence of DNA replication.
Using RNAi and inhibitors to independently target DNA replica-
tion licensing or firing, we find similar results in cancer cells.
We also find that abrogating CHK1 activity in transformed cells,
or CHK1 and p38 activity in untransformed cells, enhances CDK
activation specifically upon G1/S transition, supporting the
notion of a DNA replication checkpoint in human cells. While
checkpoint inhibition causes premature activation of CDK2,118 Molecular Cell 71, 117–128, July 5, 2018PLK1, and CDK1, we find the latter most harmful and causing se-
vere DNA replication stress.
Our results indicate that DNA replication is not only an output
but also an integral signaling component of the cell cycle oscil-
lator and is a major determinant for the timing of mitosis. DNA
replication, through checkpoint kinase signaling, coordinates
the cell cycle by allowing a slow buildup of CDK2 activity
while suppressing CDK1 and PLK1 activation until S phase
completion.
RESULTS
Nuclear PLK1 Activation Marks Completion of DNA
Replication at S/G2 Transition
In order to simultaneously monitor DNA replication and mitotic
kinase activation, we generated untransformed but immortalized
retinal pigment epithelial (RPE) cell lines expressing a marker for
DNA replication (proliferating cell nuclear antigen [PCNA]-cb)
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and a sensor for PLK1 target phosphorylation (PLK1-FRET). In
agreement with our previous findings in U2OS cancer cells,
PLK1 target phosphorylation remained undetectable during
active DNA replication and only appeared when the bulk of
PCNA foci disappeared (Figure 1B). The close correlation be-
tween PCNA foci disappearance and Plk1-mediated phosphor-
ylation was retained when completion of DNA replication was
delayed by addition of thymidine (Figures 1C, S1A, and S1B).
To test PLK1-dependent phosphorylation of an endogenous
target, we next assessed TCTP-pS46 staining (Cucchi et al.,
2010) by quantitative immunofluorescence. To estimate tempo-
ral kinetics from fixed asynchronous cell populations, we sorted
single cells based on cyclin A2 content, DNA content, and nu-
clear size (Akopyan et al., 2014, 2016). DNA replication was
assessed by measuring EdU nucleotide incorporation immedi-
ately before fixation, and PLK1 activity was determined by
PLK1-dependent TCTP-pS46 staining using a low dose of the
PLK1 inhibitor BI2536 (Figure S2A). We note that there is a close
correlation between the disappearance of EdU staining and the
appearance of BI2536-sensitive TCTP-pS46 staining in U2OS,
RPE, and early-passage primary fibroblasts (Figures 1D, S2A,
and S2B). The robust coupling between completion of S phase
and activation of PLK1 as assessed by both fixed and live read-
outs suggests that PLK1 activation can function as a marker for
the S/G2 transition in human cells.
A Double-Degron System to Prevent DNA Replication
Licensing
To assess whether PLK1 activation is restricted by DNA replica-
tion, we sought to analyze cells that progressed through the cell
cycle without replicating DNA. In yeast, mutants in the DNA repli-
cation licensing factorCdc6 can efficiently suppressDNA replica-
tion without blocking cell cycle progression (Muzi Falconi et al.,
1996;Piatti et al., 1995).We therefore setout togeneratea genetic
system that would allow rapid degradation of CDC6 in untrans-
formed human cells. We used p53/ RPE cells to avoid a
licensing checkpoint (Nevis et al., 2009; Shreeram et al., 2002)
and labeled both endogenous CDC6 alleles with an optimized
double-degron tag. The double degron is based on two protein
degradation tags: mAID (Nishimura et al., 2009) and SMASh
(Chung et al., 2015), allowing rapid depletion of endogenously
tagged CDC6d (Figures 2A, 2B, S3A, and S3B; STAR Methods).
CDC6d degradation using both mAID and SMASh prevented
EdU incorporation more efficiently than using mAID or SMASh
alone, showinganadditive effect of bothdegradation tagsonsup-Figure 2. Suppression of DNA Replication Initiation by Targeting CDC6
(A) Schematic of approach to target CDC6d degradation by a double-degron sys
(B) RPE CDC6d cells were treated as outlined, and cell lysates were probed aga
(C) RPE CDC6d cells were treated as in (B) yet fixed 48 hr post-AUX addition. EdU
EdU and cyclin A2 expression, and examples of G2 or S phase cells (dotted circles
cells. Lower panel depicts quantification of EdU intensities of S phase cells, as de
percentiles of at least 200 cells per condition. * indicates p < 0.01; Student’s t te
(D) RPECDC6d cells were treated as outlined in top panel, and anticipated cell cyc
replication in single cells. Lower graph depicts quantification of EdU staining ve
induction of EdU incorporation in early S phase cells.
(E) RPECDC6d cells were treated as outlined in top panel, and anticipated cell-cyc
shown in middle panels. Lower graph depicts quantification of EdU staining ve
targeting CDC6 and CDC7 specifically inhibits initiation of DNA replication in ear
120 Molecular Cell 71, 117–128, July 5, 2018pressingDNA replication (Figures 2C andS3B). After 48 hrCDC6d
degradation, cyclin A2 expression and CDK-mediated phosphor-
ylationof laminA/CpS22wasnot reduced, indicating that cells re-
mainedengaged in the cell cycle (FiguresS3CandS3D).Whereas
mitotic cells were abundant, they showed half the DNA content of
their control counterparts and few anaphase figures, as expected
for cells entering mitosis without sister chromatids (Figures S3E–
S3G). Taken together, our results show that the CDC6d double-
degron system can be used to suppress DNA replication.
Suppression of DNA Replication Initiation in
Unsynchronized Human Cells
We next pursued to study cell cycle progression in the absence
of DNA replication. We aimed to prevent initiation of replication,
as perturbation of ongoing replication leads to DNA damage and
cell cycle arrest (Natsume et al., 2017). Meanwhile, to avoid sec-
ondary effects due to continued proliferation with incomplete
DNA replication, we sought to detect the immediate effects of
suppressed initiation of DNA replication. To this end, we com-
bined CDC6d degradation and a CDC7 inhibitor, targeting both
origin licensing and origin firing, the two main events necessary
for initiation of DNA replication. DNA replication licensing by
CDC6 can in principle start as soon as CDK activities are reset
at anaphase. Cells depleted of CDC6d before mitotic exit should
thus be impaired in DNA replication initiation. In contrast, G1 or
S phase cells already harbor licensed origins and thus should
remain DNA replication competent despite CDC6d degradation.
To test this prediction, wemonitored EdU incorporation between
10 and 12 hr after targeting CDC6, CDC7, or both CDC6 and
CDC7. We reasoned that, at this time, G2 cells would have pro-
gressed through mitosis and recently entered S phase, whereas
G1 cells would have progressed to late S phase (Figures 2D and
2E). To independently monitor DNA replication and cell cycle po-
sition, we plotted EdU incorporation versus cyclin A2 content of
single cells. The gradual accumulation of cyclin A2 levels from
the G1/S border allows identification of cell cycle position within
S phase (Akopyan et al., 2014). As predicted, EdU incorporation
was effectively abrogated in early S phase cells, whereas it was
sustained in late S phase cells (Figures 2D and 2E). This shows
that our setup efficiently prevents initiation of DNA replication,
while allowing ongoing DNA replication to continue.
DNA Replication Determines Cell Cycle Duration
To study the direct consequence of failed DNA replication initia-
tion, we used time-lapse microscopy to follow single cells thatand CDC7
tem.
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Figure 3. DNA Replication Controls Cell Cycle Duration
(A) Asynchronous RPE CDC6d cells were treated as outlined and either fixed after a 2-hr pulse of EdU or followed by time-lapse microscopy. The level of DNA
replication initiation, measured by EdU incorporation in single early S phase cells, is correlated directly to cell cycle speed.
(B) Schematic of anticipated effect of CDC6d degradation and/or CDC7 inhibition.
(C) Cells were treated as outlined in (A) and (B), and nuclear EdU intensity was plotted versus nuclear cyclin A2 levels to monitor DNA replication during cell cycle
progression. Please note that combinedCDC6 degradation andCDC7 inhibition prevents EdU incorporation in early S phase cells. Lower panels illustrate a single
cell enteringmitosis after CDC6 degradation and/or CDC7 inhibition (i.e., upon addition of AUX/CDC7i). Illustration depicts relative timings of empirical tests (fix or
live) as well as anticipated cell fate.
(D) Tracks of single cells passing throughmitosis within 6 hr after addition of auxin or CDC7i were followed frommitosis to the followingmitosis. Grey bars indicate
mitosis, and red bars indicate interphase. See Figure S4 for example images of mitotic cells.entered mitosis shortly after destruction of CDC6d and inhibition
of CDC7 (Figures 3A and S4; Video S1). In parallel, we treated
cells with EdU and stained for cyclin A to detect efficiency of
DNA replication in S phase (Figures 3A–3C). Combined CDC6d
depletion andCDC7 inhibition decreasedmedian cell cycle dura-
tionby4hr (25%) and allowedcells to re-entermitosis as early
as 6–8 hr after cell division (Figure 3D). Initiation of DNA replica-
tion thus constitutes a major brake on cell cycle progression.
We find that only a limited amount of DNA replication is suffi-
cient to delay the cell cycle. After CDC6d depletion or CDC7inhibition alone, EdU incorporation is suppressed but still detect-
able in early S phase cells, while double treatment effectively
abolished new synthesis of DNA (Figures 3B and 3C). The
need for combined CDC6d depletion and CDC7 inhibition to effi-
ciently suppress DNA replication could in part be due to
compensatory mechanisms that enhance firing in genomic
regions where origins are sparse (Fragkos et al., 2015; Ozeri-
Galai et al., 2011) or due to the fact that CDK activity can comple-
ment CDC7 to fire a restricted set of origins (Rainey et al.,
2017). Importantly, CDC6d depletion or CDC7 inhibition aloneMolecular Cell 71, 117–128, July 5, 2018 121
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Figure 4. DNA Replication Restricts Activation of PLK1
(A) Examples of U2OS cells expressing PLK1-FRET and PCNA-cb followed in the absence or presence of combined CDC6/CDT1 RNAi. Time between images is
45 min. Please note absence of PCNA foci despite proficient PCNA-cb expression and nuclear PLK1 activation within 5 hr.
(B) U2OS cells expressing PLK1-FRET were treated as outlined in left panel and fixed after a 2-hr pulse of EdU or followed by time-lapse FRETmicroscopy. (Top)
EdU quantification of >600 single cells; nuclear EdU intensity was plotted versus nuclear cyclin A2 levels tomonitor DNA replication during cell cycle progression.
Outlined boxes indicate EdU-negative cells; please note that the three most right conditions generate cells that have intermediate cyclin A2 levels but fail to
incorporate EdU, which corresponds to the conditions that have premature PLK1 activation. (Bottom) Live-cell traces of single cells that entered mitosis within
2 hr upon addition of CDC7i were followed for 16 hr. Graphs show quantified PLK1 activity of 25 single cells.
(C) Representative single-cell traces of the different classes observed upon Cdc6/Cdt1 co-depletion. U2OS cells expressing PLK1-FRET and PCNA-cb were
transfected with control or Cdc6/Cdt1 small interfering RNA (siRNA) for 24 hr and mitotic cells were followed by live-cell imaging. The distinct classes include
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(D) Pie charts depict distribution of classes I–IV among cells depicted in (B). Whereas targeting licensing or firing can cause premature mitosis, we find the latter
approach to be most effective.postponed mitotic entry, increasing median cell cycle duration
by 10 hr (+70%; Figure 3D). The limited availability of
licensed or fired origins is expected to delay DNA replication
completion, which in turn could postpone mitotic entry. Our
results are in agreement with a threshold model in which low
levels of DNA replication are sufficient to prolong the cell cycle
while a complete block of DNA replication leads to premature
mitosis.122 Molecular Cell 71, 117–128, July 5, 2018DNA Replication Controls Activation of Plk1
To study the impact of DNA replication on activation of PLK1, we
targeted origin licensing (by depleting licensing factors CDC6
and CDT1) or origin firing (by combined CDC45 depletion and
CDC7 inhibition) in U2OS PLK1-FRET PCNA-cb cells. We find
that, after interfering with either DNA replication licensing or
origin firing, a subset of cells showed PLK1 activation 4–6 hr after
mitosis (Figures 4A, 4B, and S5A). Similarly, some cells entered
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(B) Boxplot depicts G1 phase duration of 50 single cells, as determined by the time observed between mitosis and APC/CCdh1 substrate appearance at the G1/S
transition. Boxplots indicate 10, 25, 50, 75, and 90th percentiles. n.s. indicates p > 0.5; Student’s t test.
(C) As in (B), yet boxplot depicts S phase duration as determined by the time observed between APC/CCdh1 substrate appearance and the detection of nuclear
PLK1 activity. Boxplots indicate 10, 25, 50, 75, and 90th percentiles. * indicates p < 0.01; Student’s t test.
(D) Images illustrate representative cells in S phase (13 hr post-mitosis) or G2 phase (17 hr post-mitosis).
(E) Asynchronous RPE cells were treated with EdU, CHIR-124 (Chk1i), and SB202190 (p38i) for 2 hr and during the last hour with RO-3306 (CDK1i) and NU6140
(CDK2i) as indicated. EdU is used to mark S phase cells and directly correlate the presence of DNA replication with CHK1i-induced CDK activation and DNA
damage. Graphs show DAPI, lamin A/C pS22, and H2AX pS139 for >800 cells measured by high-content microscopy. Single-cell illustrations below the graph
indicate cell cycle phases and presence of DNA replication stress.
(legend continued on next page)
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mitosis 6–8 hr after cell division, in contrast to control cells, in
which the shortest time between two cell divisions was 15 hr.
Premature PLK1 activation correlated to the absence of
PCNA-cb foci and abolished EdU incorporation in S phase
cells, indicating that premature PLK1 activation depends on sup-
pression of DNA replication (Figures 4A–4D and S5B). In agree-
ment with a threshold model, intermediate reduction of EdU
incorporation or PCNA foci delayed PLK1 activation compared
to control cells (Figure 4C). Our data suggest that DNA replica-
tion restricts activation of the mitotic kinase PLK1 and that
completion of DNA replication functions as a trigger for PLK1
activation.
CHK1/p38 Signaling Represses PLK1 Activity and Toxic
CDK1 during DNA Replication
The function of replication intermediates as direct inhibitors of
mitosis via constitutive checkpoint activation is a long-standing
yet unproven hypothesis in the cell cycle field (Enoch and Nurse,
1991; Hartwell and Weinert, 1989). Our finding that DNA replica-
tion initiation postpones cell cycle progression predicts the need
for factors that can sense ongoing DNA replication and suppress
the activity of mitotic kinases. Good candidates for such
signaling factors are DNA damage checkpoint kinases, as they
are known to control DNA replication fidelity during unperturbed
growth and inhibit PLK1 activity upon ectopic DNA damage
(Smits et al., 2000; Sørensen and Syljua˚sen, 2012). Indeed, we
find that two structurally unrelated CHK1 inhibitors cause pre-
mature PLK1 activation in replicating U2OS cells (Figure S6A).
Notably, CHK1 inhibition did not affect progression through G1
phase, but uncoupled nuclear PLK1 target phosphorylation
from on-going DNA replication, causing interphase cells to reach
high PLK1-FRET levels in the presence of PCNA-cb foci (Figures
5A–5D). Similarly, a live-cell CDK1/2-activity sensor rapidly
became saturated in U2OS cells containing PCNA-cb foci (Fig-
ures S6B and S6C). CHK1 can function synergistically with the
p38-MK2 axis (Dietlein et al., 2015), and combined CHK1/p38
inhibition increased CDK1/2-mediated phosphorylation of
lamin A/C in RPE cells (Figure 5E). These data support the notion
that mitotic kinases are actively suppressed during S phase.
Loss of CDK1/2 regulation is highly genotoxic and causes
DNA replication stress (Sørensen and Syljua˚sen, 2012). Accord-
ingly, inhibition of CHK1/p38 leads to phosphorylation of the
DNA damage marker H2AX specifically in replicating cells (Fig-
ures 5E, 5F, and S6D). A short pulse of CDK activity is likely suf-
ficient to induce DNA damage, as contrary to CDK inhibition 1 hr
after CHK1/p38 inhibition, simultaneous addition of all inhibitors
abolished H2AX phosphorylation (Figures 5E, 5G, S6E, and S6F).
Whereas addition of a CDK2 inhibitor decreased EdU incorpora-
tion in S phase cells, inhibition of CDK1 suppressed phosphory-
lation of H2AX (Figures 5G and S6F). Although this does not rule
out overlapping functions of CDK1 and CDK2, it suggests that
CDK1 activity is the major toxic component for replicating cells.(F) RPE cells were treatedwith CHIR-124 (CHK1i) and SB202190 (p38i) as indicate
show quantifications of high-content microscopy for H2AX pS139 in single cells.
(G) RPE cells were treated with CHIR-124 (CHK1i), SB202190 (p38i), NU6140
indicated for 4 hr. Before fixation, cells were incubated for 1 hr with EdU. Boxplots
EdU positive cells, as assessed by high-content microscopy. *** indicates p < 0.
124 Molecular Cell 71, 117–128, July 5, 2018Thus, CDK2 activity stimulates DNA replication (Coverley et al.,
2002; Walter, 2000), which in turn activates checkpoint kinases
to restrict CDK1 and PLK1 activity. As a consequence, DNA
replication is part of a feedforward system that restricts mitotic
kinase activation to prevent replication stress.
DNA Replication Checkpoint Acts after G1/S Transition
to Limit CDK Activation
A prediction of such a system is that DNA replication continu-
ously restricts CDK activity. We therefore sought to monitor
CDK activity as cells entered S phase. A live sensor for
CDK1/2 activity shows a gradual increase, starting from before
S phase is initiated (Cappell et al., 2016; Figure 6A). In the pres-
ence of CHK1 inhibition, we detect no difference in CDK1/2
sensor localization through G1 phase (Figures 6A–6C). However,
we detect enhanced CDK activity from the moment cells enter
S phase as estimated by appearance of PCNA-cb foci (Figures
6A and 6B) or by expression of an anaphase-promoting complex
(APC)/CCdh1 substrate reporter (Cappell et al., 2016; Figure 6C).
Similarly, blocking DNA replication licensing or DNA replication
firing causes elevated CDK activity upon S phase entry (Figures
6D–6F). We also detect elevated CDK1/2-mediated phosphory-
lation of Lamin A/C pS22 in cells in which DNA replication initia-
tion is prevented by targeted destruction of CDC6d (Figures
S7A–S7C). Thus, rather than merely a consequence of cell cycle
signaling (Krude et al., 1997), DNA replication coordinates
gradual CDK activation throughout S phase with activation of
mitotic kinases PLK1 and CDK1 after completion of S phase
(Figure 7).
DISCUSSION
Separation of DNA replication and cell division lies at the heart of
the cell cycle. Several not mutually exclusive models for how
cells ensure completion of DNA replication before mitosis have
been proposed (reviewed in Uhlmann et al., 2011). Thesemodels
include (1) a slow buildup of CDK activity coupled to different
thresholds for starting DNA replication and mitosis (Stern and
Nurse, 1996), (2) different cyclin proteins appear at given times
and cellular locations (Murray, 2004), (3) transcriptional oscillator
networks (Haase and Reed, 1999; but see also Rahi et al., 2016),
and (4) a checkpoint that restricts mitosis before DNA replication
is completed (Hartwell and Weinert, 1989). Our results suggest
that, in human cells, DNA replication is a major determinant of
cell cycle duration and timing of mitosis. We propose that DNA
replication functions as a continuous brake with the possibility
to separate and coordinate different cell cycle activities.
We find that severe suppression of DNA replication initiation is
required to prematurely activate mitotic kinases and to advance
mitotic entry. For instance, CDC7 inhibition or CDC6 degradation
alone postpones mitotic entry, while combined treatment
advances mitotic entry (Figure 3). This suggests that a thresholdd. To define S phase, cells were incubated with EdU 1 hr prior to fixation. Panels
Cell populations were separated according to DAPI and EdU intensity.
(CDK2i), RO3306 (CDK1i), CDK1/2 inhibitor III (CDK1/2i), and Roscovitine as
show 90, 75, 50, 25, and 10th percentiles of EdU signal or H2AX pS139 signal of
001, and ns indicates p > 0.1; Student’s t test.
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Figure 6. DNA Replication Limits CDK1/2 Activation upon S Phase Entry
(A) Single U2OS cells were filmed upon mitotic exit, and cells that were ±1 hr from mitosis upon addition of CHIR-124 (CHK1i) were selected for analysis.
Montages depict an example cell expressing CDK1/2 activity sensor and PCNA-cb followed by time-lapse microscopy. Time between images is 45min. Note the
rapid cytoplasmic translocation of the CDK1/2 sensor at the G1/S transition in the presence of CHK1i. Please see Figure S6C for readout details.
(B) Quantification of single cells imaged as in (A). Red line indicates relative CDK1/2 activity, and blue line indicates PCNA-cb intensity variation as a surrogate
measurement for DNA replication. Grey lines show average CDK1/2 activity of control cells. To illustrate concurrence at G1/S, three single cells with different G1
lengths are depicted.
(C) U2OS cells expressingCDK1/2 activity sensor and APC/CCdh1 substrate (GEM-RED) after CHIR-124 treatment and followed as in (A). To illustrate concurrence
at G1/S, two single cells with different G1 lengths are depicted.
(D) Quantification of single cells imaged as in (A) yet 24 hr after transfection of Cdc6 and Cdt1 siRNA. Red line indicates relative CDK1/2 activity, and blue line
indicates PCNA-cb intensity variation as a surrogate measurement for DNA replication. Grey lines show average CDK1/2 activity of control cells.
(legend continued on next page)
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Figure 7. Model for Integral Role of DNA Replication in Human Cell
Cycle Wiring
Proposed model in which DNA replication constitutes a functional output as
well as an integral component of an incoherent feedforward loop in human cell
cycle signaling. DNA replication generates a CHK1- and p38-dependent signal
that prevents premature mitosis and CDK1-driven DNA damage in S phase.of replication activity exists, under which mitotic entry is not
prevented. DNA replication in human cells is performed by thou-
sands of replication forks (Chagin et al., 2016). How many repli-
cation forks are required to reach this threshold is not clear.
However, it is likely that a single replication fork is not sufficient
to block mitotic entry as Plk1 activation is observed in the pres-
ence of occasional weak PCNA-cb foci (Akopyan et al., 2014)
and DNA synthesis at fragile sites has been detected in mitotic
cells (Minocherhomji et al., 2015; Pedersen et al., 2015).
While complete DNA replication is critical for proper chromo-
some segregation in mitosis, DNA replication per se is not a pre-
requisite for mitotic entry. Yeast mutants lacking CDC6, CDT1,
ORC2, RFC5, CDC45, or CDC7/DBF4 enter mitosis with unrepli-
cated chromatids (Dowell et al., 1994; Hofmann and Beach,
1994; Liang et al., 1995; Piatti et al., 1995; Sugimoto et al.,
1996). Whether mitotic entry in these studies depends on
gene-specific functions independent of DNA replication initiation
has been debated (Bueno andRussell, 1992). Given that all these
proteins have in common to affect initiation of DNA replication,
we consider that the most likely explanation involves initiation
of DNA replication. In support of this notion, we detect premature
mitotic kinase activation and shorter cell cycles in the absence
of DNA replication origin licensing and/or origin firing in hu-
man cells.
Once initiated, CDK2 activity will promote both DNA replica-
tion and stimulate CDK1 and PLK1 activity (Fu et al., 2008; Ghe-
ghiani et al., 2017). However, at the same time, CDK1 and PLK1
are restricted by DNA replication, constituting an incoherent
feedforward loop (Figure 7). Given that CDK1 activation causes
DNA damage during DNA replication, there is a possibility that
the feedforward loop is complemented by feedback between
CDK1 and DNA replication, ensuring a continuous low level of
checkpoint activation. We note that a feedforward system not
only ensures that mitosis is avoided until DNA replication is
completed but also can ensure that mitotic kinase activation
commences immediately after S phase, ensuring a tight coupling
between S phase and mitosis.
The feedforward loop between CDK2, DNA replication, and
mitotic kinase activation contributes to genome stability in two(E) U2OS cells expressing CDK1/2 activity sensor and APC/CCdh1 substrate (GE
single cells with different G1 lengths are depicted per condition.
(F) Quantification of CDK1/2 reporter of cells monitored as in (C) and (E). G1 is defin
reporter. Graph shows mean and SD of 14 cells per condition. *p < 0.04; Studen
126 Molecular Cell 71, 117–128, July 5, 2018ways. First, it ensures that mitosis is delayed until the bulk of
DNA is duplicated. Second, it prevents DNA replication stress
and CDK1-mediated DNA damage. In this sense, complete
deregulation of the feedforward loop likely is lethal, whereas
slight perturbations have the possibility to contribute to CDK-
dependent DNA lesions in S phase (Lecona and Ferna´ndez-
Capetillo, 2014; Szakal and Branzei, 2013; Zhang and Hunter,
2014) and might promote the occurrence of underreplicated
DNA in mitosis (Lukas et al., 2011; Minocherhomji et al., 2015).
Such perturbations may not only have consequences for mitosis
but also for G1 duration and cell fate of daughter cells (Arora
et al., 2017; Barr et al., 2017).
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
CyclinA2 Santa Cruz sc-751
CyclinA2 Cell Signaling 4656
PLK1 Abcam ab14210
pTCTP Cell Signaling Technology 5251
pH2AX Cell Signaling Technology 2577
pCyclinB1 Abcam ab55184
pLaminA/C Cell Signaling Technology 2026
Alexa Fluor 488 Goat anti-Rabbit Life Technologies A11008
Alexa Fluor 555 Goat anti-Mouse Life Technologies A21422
CDC6 Santa Cruz sc-9964
CDT1 Santa Cruz sc-28262
GAPDH Sigma G8795
Anti-Rabbit HRP Abcam ab6721
Anti-Mouse HRP Abcam ab97023
Chemicals, Peptides, and Recombinant Proteins
CHIR-124 Selleck Chemicals S2683
UCN-01 Sigma U6508
RO-3306 Calbiochem 217699
NU6140 Calbiochem 238804
Roscovitine Selleck Chemicals S1153
CDK1/2 inhibitor III Millipore 217714
SB202190 Selleck Chemicals S1077
BI2536 Selleck Chemicals S1109
GSK461364 Selleck Chemicals S2193
XL-413 Selleck Chemicals S7547
BMS-650032 Adooq Bioscience A11295
3-Indoleacetic acid Sigma-Aldrich I3750
Doxycycline Sigma-Aldrich D3447
Experimental Models: Cell Lines
BJ ATCC CRL-2522
U2OS Rene Medema (NL) N/A
Human hTERT-RPE1 Rene Medema (NL) N/A
Human hTERT-RPE1 p53KO Libor Macurek (CZ) N/A
Oligonucleotides
CDC6 siRNA SMARTpool ON-TARGET plus Dharmacon 003233
Non-targeting siRNA SMARTpool ON-TARGET plus Dharmacon 001810
CDC45 siRNA SMARTpool ON-TARGET plus Dharmacon 003232
CDT1_7 siRNA Flexitube QIAGEN SI04142250
CDT1_8 siRNA Flexitube QIAGEN SI04159477
Recombinant DNA
pCCC-TagRFP (PCNAcb) Chromotek N/A
pCSII-EF-Cdk2probe Sabrina Spencer (US) N/A
pRetroX-SG2M-Red Clontech 631465
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REAGENT or RESOURCE SOURCE IDENTIFIER
hCDC6_mAID_SMASh_T2A_Neo This paper N/A
pROSA26-DV1_OsTIR This paper N/A
PX458_Cas9_GFP Addgene 48138
PX458_Cas9_GFP_hCDC6 This paper N/A
Software and Algorithms
ImageJ 1.51h ImageJ https://imagej.nih.gov
MATLAB R2015b MathWorks https://www.mathworks.com
CellProfiler 2.2.0 CellProfiler http://cellprofiler.orgCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Arne
Lindqvist (arne.lindqvist@ki.se).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Source of cell lines used in this study is reported in the Key Resources Table.
METHOD DETAILS
Cell Culture
Human hTERT-RPE1 (hereafter referred to as RPE), U2OS and BJ cells were cultured in an ambient-controlled incubator at 37C and
5% CO2. Early passage BJ cells were purchased from ATCC (CRL-2522) and examined prior to population doubling 10. RPE and
U2OS cells were a kind gift from Dr. Rene´ Medema. All cell lines were regularly tested for mycoplasma. RPE cells were cultured using
DMEM-F12 GlutaMAX (Invitrogen) supplemented with 1%Pen/Strep (HyClone) and 10%heat-inactivated FBS (HyClone). U2OS and
BJ cells were cultured using DMEM GlutaMAX (Invitrogen) supplemented with 1% Pen/Strep (HyClone) and 6% or 10% heat-inac-
tivated fetal bovine serum (FBS, HyClone), resp.
Plasmids and Cell lines
Reporter plasmids pCCC-TagRFP (Chromotek, PCNA-cb), pCSII-EF-Cdk2probe (Spencer et al., 2013) or pRetroX-SG2M-Red
(Clontech, 631465) were used to obtain stable cell lines by random plasmid integration. Plasmid transfection was performed using
LipofectAMINE 2000 Reagent (Life Technologies) or standard calcium phosphate precipitation. Stable polyclonal populations were
selected by flow cytometry using BD-FACSAria II and correct expression patterns were validated by live-cell microscopy.
TP53 knockout RPE cells were from Silva Cascales et al. (2017). Stable OsTIR expression was established by CRISPR-mediated
integration: Transient GFP+ cells were sorted 3 days post transfection of pROSA26-DV1_OsTIR and PX458_Cas9_GFP (Addgene
48138) and subsequently subjected to bleomycin selection. For inducible expression of OSTir1 we used a previously described
construct (Natsume et al., 2016) that was combinedwith a bleomycin selection cassette and cloned into a Rosa26 targeting construct
to generate pROSA26-DV1_OsTIR. To target the human Rosa26 locus we used the following gRNA sequence: 50 GACCTGCTA
CAGGCACTCGT 30 cloned into pPV576_gRNA_ROSA26. Subsequent double degron tagging at the human CDC6 locus was estab-
lished through CRISPR-mediated targeting: First a CDC6 guide sequence was cloned into PX458_Cas9_GFP (Addgene 48138) using
BbSI sites and two annealed oligos CACCGC CAGCTG AATACT TTCGGG and AAACCC CGAAAG TATTCA GCTGGC. Second, a
tagging vector was generated named hCDC6_mAID_SMASh_T2A_Neo, by cloning CDC6 homology arms (gBlock IDT) into a
mAID_SMASh_T2A_Neo backbone using SbfI and NotI sites. The mAID_SMASh_T2A_Neo backbone was constructed via Gibson
assembly cloning.
The resultant PX458_Cas9_GFP_hCDC6 and hCDC6_mAID_SMASh_T2A_Neo vectors were sequence-verified and transfected
into OsTIR-RPEP53KO cells. Three days post transfection GFP+ cells were sorted and subjected to Geneticin selection (G418;
GIBCO). Clonal cell lines were established by limiting dilution in a 96-well plate. Successful Cdc6 degron-tagging in single clones
was verified by western blot and degron-induced growth arrest.
RNA Interference and Inhibitors
Knockdown studies were performed using SMARTpool scrambled control siRNA (Dharmacon), SMARTpool ON-TARGET plus CDC6
siRNA (Dharmacon), SMARTpool ON-TARGET plus CDC45 siRNA (Dharmacon), FlexiTube Hs_CDT1_7 (QIAGEN) and FlexiTubee2 Molecular Cell 71, 117–128.e1–e3, July 5, 2018
Hs_CDT1_8 (QIAGEN). siRNAs were transfected at 20nM concentration using HiPerFect reagent (QIAGEN) and OptiMEM
(Invitrogen). The following small-molecule inhibitors were used at the indicated final concentrations: 50 nMCHIR-124 (CHK1 inhibitor;
Selleck Chemicals), 30nM UCN-01 (CHK1 inhibitor; Sigma), 5 uM RO-3306 (Cdk1 inhibitor; Calbiochem), 10 uM NU6140 (Cdk2 in-
hibitor; Calbiochem), 25uM Roscovitine (Cdk1/2 inhibitor; Selleck Chemicals), 3uM CDK1/2 inhibitor III (Millipore),10 uM SB202190
(p38 inhibitor; Selleck Chemicals), 50 nM BI2536 (PLK1 inhibitor, Selleck Chemicals), 200nM GSK461364 (PLK1 inhibitor; Selleck
Chemicals), 2.5 mM Thymidine (Sigma Aldrich), 15 uM XL-413 (CDC7 inhibitor; Selleck Chemicals), 100 nM BMS-650032 (Asunap-
revir; Adooq Bioscience), 50 uM 3-Indoleacetic acid (Auxin; Sigma Aldrich), 1ug/ml Doxycycline (Sigma Aldrich).
Live-Cell Microscopy and Quantitative Immunofluorescence
For time-lapse microscopy of RPE CDC6d cells (Figure 2D), transmitted light images were acquired every 10 min using a Leica
DMI6000 Imaging System with 20x (NA 0.4) air objective at 37C and 5% CO2. Images were analyzed using ImageJ and cells
were tracked manually. For live cell fluorescence imaging experiments, 6000-9000 cells were seeded in 96-well imaging plates
(BD Falcon) in DMEM with 1% Pen/Strep and 6%–10% FBS and at least 6 hr prior to imaging the medium was changed to
Leibowitz-15 (Invitrogen) with 1% Pen/Strep and 6%–10% FBS. Images were acquired at 37C at 20-45min intervals using
ImageXpress microscope (Molecular Devices) 20X objective (NA 0.45) and analyzed using custom ImageJ or MATLAB scripts
(Akopyan et al., 2014; Hukasova et al., 2012). PLK1 FRET was measured using ImageJ (Akopyan et al., 2014; Hukasova et al.,
2012), using rolling ball background subtraction, 3x YFP signal multiplication and RatioPlus plugin (background 0 and clipping values
25-50). Normalized PCNA-cb intensity variation (i.e., standard deviation of nuclear RFP signal divided by median nuclear RFP inten-
sity) is used as a surrogate measurement for DNA replication; the last few bright PCNA foci at the end of S-phase cause a charac-
teristic peak in PCNA-cb intensity variation (Figures 1C and 4C). CDK1/2 activity probe was analyzed using ImageJ; nuclear ROIs
were selected manually and ratio between nuclear YFP intensities and cytoplasmic YFP intensities was determined using custom
ImageJ macro’s and Excel (see Data S1 for example macro). For quantitative IF experiments 6000-9000 cells were seeded in
96-well imaging plates (BD Falcon) in DMEM with 1% Pen/Strep and 6%–10% FBS and after treatment washed in DPBS (GIBCO),
fixed in formalin (Sigma Aldrich) for 7 min, permeabilised in cold methanol (Sigma Aldrich) for 2 min and finally incubated in blocking
media (TBS supplemented with 0.1% Tween20 and 2% bovine albumin serum) for 1 hr at room temperature. For pulse-chase exper-
iments or DNA replication measurements 10mM EdU (5-ethynyl-20-deoxyuridine, Molecular probes) was added to live cells prior to
fixation. Fixed samples were incubated with primary antibodies in blocking media overnight at 4C, washed in DPBS (GIBCO) and
incubated with secondary antibodies and DAPI for 1h at room temperature. Samples were stored in PBS and in case of DNA repli-
cation measurements EdU-Click chemistry was performed by incubation in 100mM Tris, 1mM CuSO4, 100mM ascorbic acid
and fluorescent dye azide (#A10277, Invitrogen) for 1h at room temperature. Images were acquired at room temperature using
ImageXpress microscope (Molecular Devices) 20X objective (NA 0.45) and analyzed using custom Cell profiler pipelines. To assess
kinetics and cell cycle stages from quantitative IF data, cells were ordered and distributed linearly based on increasing nuclear Cyclin
A2 intensities and normalized DAPI levels (Akopyan et al., 2016). For RPE and BJ cells in Figure 1C, cells containing low DAPI levels
(corresponding to undermid S-phase levels) were sorted based on the ratio between nuclear size and roundness, and remaining cells
were sorted by Cyclin A2 content.
Antibodies
The following antibodies were used for IF and diluted in TBS supplemented with 0.1% Tween20 and 2% BSA: CyclinA2 (1:400; #sc-
751; Santa Cruz), CyclinA2 (1:400; #4656; Cell Signaling), PLK1 (1:400; ab14210; Abcam), pTCTP (1:400; #5251; Cell Signaling),
pH2AX (1:800; #2577; Cell Signaling), pCyclinB1 (1:400; #ab55184; Abcam), pLaminA/C (1:400; #2026; Cell Signaling), Alexa Fluor
488-Goat anti-Rabbit (1:2000; #A11008 Life Technologies) and Alexa Fluor 555-Goat anti-Mouse (1: 2000; #A21422 Life Technolo-
gies). The following antibodies were used for WB and diluted in TBS supplemented with 0.1% Tween20 and 5% milk powder:
CDC6 (1:400; #sc-9964 Santa Cruz), CDT1 (1:400; #sc-28262 Santa Cruz), GAPDH (1:20000; #G8795; Sigma), anti-Rabbit HRP
(1:2000; #ab6721; Abcam) and anti-Mouse HRP (1:2000; #ab97023; Abcam).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed using the Student’s t test. Quantitative IF studies included >200 cells per conditions and represent
at least two independent experiments. Qualitative example images are representative for >10 independent biological replicates. In-
formation about the statistical tests and the number of cells analyzed is provided in the figure legends. For all experiments, samples
were not randomized and the investigators were not blinded to the group allocation during experiments and outcome assessment.
DATA AND SOFTWARE AVAILIBILTY
Original imaging data have been deposited to Mendeley Data and are available at https://doi.org/10.17632/47s44zbm7c.1.Molecular Cell 71, 117–128.e1–e3, July 5, 2018 e3
